Grace M Callagy

Summary

Affiliation: National University of Ireland
Country: Ireland

Publications

  1. ncbi request reprint Bcl-2 is a prognostic marker in breast cancer independently of the Nottingham Prognostic Index
    Grace M Callagy
    Cancer Genomics Program, Department of Oncology, Hutchison Medical Research Council Research Centre, University of Cambridge, United Kingdom
    Clin Cancer Res 12:2468-75. 2006
  2. pmc Malignant phyllodes tumour with liposarcomatous differentiation, invasive tubular carcinoma, and ductal and lobular carcinoma in situ: case report and review of the literature
    Mardiana Abdul Aziz
    Division of Anatomic Pathology, Galway University Hospitals, Galway, Ireland
    Patholog Res Int 2010:501274. 2010
  3. pmc Prognostic significance of deregulated dicer expression in breast cancer
    Emer Caffrey
    School of Medicine, Clinical Science Institute, National University of Ireland, Galway, Ireland
    PLoS ONE 8:e83724. 2013
  4. pmc Meta-analysis confirms BCL2 is an independent prognostic marker in breast cancer
    Grace M Callagy
    Department of Pathology, National University of Ireland, Galway, Clinical Science Institute, Costello Road, Galway, Ireland
    BMC Cancer 8:153. 2008
  5. ncbi request reprint A recurrent chromosome breakpoint in breast cancer at the NRG1/neuregulin 1/heregulin gene
    Huai En Huang
    Cancer Genomics Program, Hutchison MRC Research Centre, Department of Pathology, University of Cambridge, Cambridge, United Kingdom
    Cancer Res 64:6840-4. 2004

Collaborators

Detail Information

Publications5

  1. ncbi request reprint Bcl-2 is a prognostic marker in breast cancer independently of the Nottingham Prognostic Index
    Grace M Callagy
    Cancer Genomics Program, Department of Oncology, Hutchison Medical Research Council Research Centre, University of Cambridge, United Kingdom
    Clin Cancer Res 12:2468-75. 2006
    ..We validated the results in an independent series. Experimental Design and..
  2. pmc Malignant phyllodes tumour with liposarcomatous differentiation, invasive tubular carcinoma, and ductal and lobular carcinoma in situ: case report and review of the literature
    Mardiana Abdul Aziz
    Division of Anatomic Pathology, Galway University Hospitals, Galway, Ireland
    Patholog Res Int 2010:501274. 2010
    ..This case highlights the diverse pathology that can occur with PTs, which should be considered when evaluating pathology specimens as they may impact on patient management...
  3. pmc Prognostic significance of deregulated dicer expression in breast cancer
    Emer Caffrey
    School of Medicine, Clinical Science Institute, National University of Ireland, Galway, Ireland
    PLoS ONE 8:e83724. 2013
    ..Aberrant expression of Dicer is reported in several human cancers. Our aim was to assess the prognostic role of Dicer in breast cancer...
  4. pmc Meta-analysis confirms BCL2 is an independent prognostic marker in breast cancer
    Grace M Callagy
    Department of Pathology, National University of Ireland, Galway, Clinical Science Institute, Costello Road, Galway, Ireland
    BMC Cancer 8:153. 2008
    ..Here, we present the results of a meta-analysis of the association between BCL2 expression and both disease free survival (DFS) and overall survival (OS) in female breast cancer...
  5. ncbi request reprint A recurrent chromosome breakpoint in breast cancer at the NRG1/neuregulin 1/heregulin gene
    Huai En Huang
    Cancer Genomics Program, Hutchison MRC Research Centre, Department of Pathology, University of Cambridge, Cambridge, United Kingdom
    Cancer Res 64:6840-4. 2004
    ..They were, like breast tumors in general, mainly ErbB2 low (11 of 13 were low) and estrogen receptor positive (11 of 13 positive)...